- 01 May, 2024
Geopolitics & National SecurityCOVAXIN
Single Covaxin jab in previously COVID infected individuals equivalent to two doses in infection-naive persons: Study
New Delhi [India], August 28 (ANI): A single dose of Covaxin for previously COVID-19 infected individuals is equivalent to two doses of the vaccine in infection-naive individuals, suggests the pilot…
Union Minister Mansukh Mandaviya meets WHO Chief Scientist Dr Soumya Swaminathan, discusses WHO’s approval of Covaxin
New Delhi [India], August 12 (ANI): Union Health Minister Mansukh Mandaviya on Thursday met World Health Organization (WHO) Chief Scientist Dr Soumya Swaminathan and held a discussion over the world…
Mix of Covishield, Covaxin yields better results: ICMR Study
By Shalini Bhardwaj New Delhi [India], August 8 (ANI): The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the…
Facility augmentation of Bharat Biotech, 3 other PSEs being supported for augmented production of Covaxin
New Delhi [India], August 7 (ANI): The Union Ministry of Chemicals and Fertilizers on Friday informed that facility augmentation of Bharat Biotech and three other public sector enterprises (PSEs) are…
Covaxin receives certificate of Good Manufacturing Practice from Hungarian authorities
New Delhi [India], August 5 (ANI): Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities. "Another milestone in…
Covaxin is effective against Delta Plus variant of Covid-19, says study
New Delhi [India], August 2 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has shown less reduction in 'neutralizing activity' while comparing with Delta and Delta AY.1 (Delta plus) variants in those…
Expert panel recommends trials on mixing Covaxin and Covishield
By Shalini Bhardwaj New Delhi [India], July 30 (ANI): The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Thursday recommended granting permission for trials of…
COVAXIN trial results on children likely by September: AIIMS chief Dr Randeep Guleria
By Shalini Bhardwaj New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All…
Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin
New Delhi [India], July 23 (ANI): Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to…
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO
New Delhi [India], July 19 (ANI): Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use…
EUL to Covaxin from WHO expected in first week of August: Sources
By Shalini Bhardwaj Geneva [Switzerland], July 10 (ANI): The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce…
After release of Covaxin’s phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition
By Shalini Bhardwaj New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI)…
